This page records the Discussion Group's meeting notes for August 2016. We meet Tuesdays for 30 minutes at 7:30am PT / 10:30am ET / 3:30pm UK / 4:30pm CET. We meet Thursdays for 30 minutes at 11am PT / 2pm ET / 7pm UK / 8pm CET. US times are normative during daylight saving time changes. We use Kantara Line A (US +1-805-309-2350, Skype +99051000000481, international options, web interface, more info, code 4022737) and http://join.me/findthomas for screen sharing. See the DG calendar for our full meeting schedule. Previous meeting minutes are here: July.
...
John: this is ok, but it doesn't convey the transparency of usage back to the data holder and patient. A "template" of the SC could be used. Kathleen: templates themselves can be analyzed and adjudicated/? John: similarities with Thomas's use case.
Thomas: yes, lots of similarities. We need to tease-out common components and building block. Kathleen/John: there are 2 usages of blockchain: (a) for recording, and (b) for enforcing. One can live without the other. Incrementally can move forward with one or the other, not both. John: part of the research statement and agreement, it should call out that it has to make use of blockchain and SC in a given way. Transparency addresses through preconditions (e.g. pseudo-identifier) defined elsewhere. We just define the usage/functionality that it provides.
Thursday August 18
Agenda:
...
The biggest question: Is there a role for the blockchain? The three lightbulbs highlight the particular steps where this comes into play. (Scott suggested to the chat that the lightbulbs in the recent edit can be broken out into individual use cases. As mentioned on the call, the use cases will form an ontology, these would be different instances of “record X on a ledger”, with a different X for each lightbulb.) Thomas notes there is a bit of a crisis of repeatability in research. Could that be addressed with the new technologies somehow? John suspects that this is where putting the protocols (the descriptions of the studies) themselves on the blockchain would be more productive, and this is where his mention of a "predecessor or stereotypical case" of Human Research Consent could encompass that solution. He points to https://clinicaltrials.gov.
...